Novel pDNA particles for pulmonary administration
Methods have been successfully developed and evaluated to aerosolise surfactant-coated pDNA particles and maintain pDNA viability. Furthermore, investigations have demonstrated that the pDNA particles and a transfection agent (DOTAP) can be incorporated into a generic HFA134a formulation and success...
Main Author: | |
---|---|
Published: |
Cardiff University
2010
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.585057 |